SDC1 and Miyoshi myopathy: GLVGLIFAV (also known as L-valine-glycyl-l-leucyl-l-valylglycyl-l-leucyl-l-isoleucyl-l-phenylalanyl-l-alanyl- or CD138260–268) is a short and immunogenic human leukocyte antigen A2 (HLA-A2)-specific CD138 epitope nanomer, which elicits a restricted cytotoxic T lymphocyte (CTL) response to MM cells positive to CD138 and HLA-A2 expression (195).